Phase II trial of low-dose cyclo-phosphamide, leucovorin, high-dose 5-fluorouracil 24-hour continuous infusion and tamoxifen in advanced biliary tract cancer-Reference-Cited by-同舟云学术

Phase II trial of low-dose cyclo-phosphamide, leucovorin, high-dose 5-fluorouracil 24-hour continuous infusion and tamoxifen in advanced biliary tract cancer

Published:2000-06 Issue:6 Volume:11 Page:762-763
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Eckel F.,Lersch C.,Assmann G.,Schulte-Frohlinde E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/11/6/762/19478649/11-6-762.pdf

Reference10 articles.

1. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma;Altaee;Cancer,1991

2. Nonspecific immunostimulation with low doses of cyclophosphamide (LDCY), thymostimulin, and Echinacea purpurea extracts (echinacin) in patients with far advanced colorectal cancers: Preliminary results;Lersch;Cancer Invest,1992

3. Continuous infusion of chemotherapy: Focus on 5-fluorouracil and fluorodeoxyuridine;Poorter;Pharm World Sci,1998

4. Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: Results of a randomized trial in patients with advanced colorectal cancer;Köhne;J Clin Oncol,1998

5. Systemic treatment options in advanced colorectal cancer: Perspectives on combination 5-fluorouracil plus leucovorin;Grem;Semin Oncol,1997

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioenergetic alteration in gastrointestinal cancers: The good, the bad and the ugly;World Journal of Gastroenterology;2023-08-07

2. Tamoxifen: The Past, Present, and Future of a Previous Orphan Drug;European Journal of Medical and Health Sciences;2022-05-24

3. Biliary tract carcinomas: From chemotherapy to targeted therapy;Critical Reviews in Oncology/Hematology;2013-02

4. Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials;British Journal of Cancer;2007-02-27

5. Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer;Cancer Chemotherapy and Pharmacology;2006-12-02